Scientists found a molecule that helps tumours in an especially deadly form of breast cancer have grow and spread. The molecule, known as alpha v beta 6, could be used both to identify at-risk patients and develop new treatments, say scientists.
A study found high levels of alpha v beta 6 in 40% of tumours in women with HER2 positive breast cancer, a form of the disease that does not respond to conventional hormone therapy. These patients were twice as likely to die within five years of diagnosis as those with low levels of the molecule.
In experiments on mice with the same type of breast cancer, scientists used an antibody drug to block activity of alpha v beta 6. Combining the antibody with the drug Herceptin, which targets the cancer-driving HER2 protein, completely eradicated the animals' tumours after six weeks of treatment.
More top news
The abusive pasts of more than 1,300 violent partners have been disclosed under a scheme introduced less than a year ago, new figures show.
David Cameron has said he wants to cut taxes after the next election because British people "deserve a reward" following years of austerity.
The number of pothole compensation claims is rising and campaigners have urged the Government to pledge more money to fix Britain's roads.